We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.16B
AUM Growth
-$821M
Cap. Flow
-$392M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$145M
2
ASML icon
ASML
ASML
+$119M
3
QRVO icon
Qorvo
QRVO
+$89M
4
MSFT icon
Microsoft
MSFT
+$82.9M
5
ISRG icon
Intuitive Surgical
ISRG
+$75.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.56%
2 Technology 29.01%
3 Industrials 8.79%
4 Communication Services 5.99%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA.WS
551
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$207K ﹤0.01%
+235,100
New +$262K
FUSN
552
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$200K ﹤0.01%
25,703
-217,637
-89% -$1.58M
RGF
553
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$198K ﹤0.01%
2,083
WPCA
554
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
$197K ﹤0.01%
20,000
ALTIW
555
DELISTED
AlTi Global Inc Warrant
ALTIW
$188K ﹤0.01%
300,000
+283,334
+1,700% +$203K
HMCOW
556
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$169K ﹤0.01%
527,660
FFAIW
557
DELISTED
Faraday Future Intelligent Electric Warrant
FFAIW
$168K ﹤0.01%
+188,700
New +$163K
ALDX icon
558
Aldeyra Therapeutics
ALDX
$95.9M
$164K ﹤0.01%
36,855
-739,379
-95% -$2.95M
ORIC icon
559
Oric Pharmaceuticals
ORIC
$1.34B
$155K ﹤0.01%
+29,095
New +$262K
AEAE
560
DELISTED
AltEnergy Acquisition Corp
AEAE
$149K ﹤0.01%
+15,000
New +$148K
GOEVW
561
DELISTED
Canoo Inc. Warrant
GOEVW
$137K ﹤0.01%
+115,400
New +$165K
CNTB
562
Connect Biopharma Holdings
CNTB
$138M
$132K ﹤0.01%
+43,871
New +$185K
FLNC icon
563
Fluence Energy
FLNC
$2.44B
$131K ﹤0.01%
10,000
PEGRW
564
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$124K ﹤0.01%
+225,000
New +$116K
SLCRW
565
DELISTED
Silver Crest Acquisition Corporation Warrant
SLCRW
$123K ﹤0.01%
274,037
+106,683
+64% +$44.1K
NBTX
566
Nanobiotix
NBTX
$1.92B
$121K ﹤0.01%
17,288
-25,284
-59% -$200K
MAPSW
567
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$120K ﹤0.01%
+54,500
New +$69.1K
NRDS icon
568
NerdWallet
NRDS
$582M
$120K ﹤0.01%
10,000
THRN
569
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$115K ﹤0.01%
18,154
-81,846
-82% -$441K
LLAP.WS
570
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
$111K ﹤0.01%
+225,000
New +$132K
NAACW
571
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$93K ﹤0.01%
+300,000
New +$132K
WEAV icon
572
Weave Communications
WEAV
$530M
$89K ﹤0.01%
14,999
PAQCW
573
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
$79K ﹤0.01%
+187,500
New +$83.7K
FOUNW
574
DELISTED
Founder SPAC Warrants
FOUNW
$78K ﹤0.01%
+180,683
New +$95.8K
LUNRW
575
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$74K ﹤0.01%
150,000

Similar funds

Woodline Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.

  • Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
  • Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
  • Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
  • Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
  • Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
  • Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.